Thrombocytopenia Clinical Trials

237 clinical trials for Thrombocytopenia across international registries, including 23 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Contribution of Anti-platelet Antibodies Identified With MAIPA Assay in the Demonstration of the Auto-immune Character of a Thrombocytopenia at Diagnosis — RECRUITING · NA
• Prediction of Platelet Function Using Viscoelastic Test (ROTEM® Sigma) in Obstetric Anesthesia. — RECRUITING
• Safety and Efficacy of Umbilical Cord Blood Therapy for Cancer Therapy-Induced Thrombocytopenia (CTIT) — RECRUITING · PHASE2
• Apixaban in Thrombocytopenia — RECRUITING · PHASE1
• Neonatal Platelet Transfusion Threshold Trial — RECRUITING · NA
• Luspatercept for Clonal Cytopenias of Uncertain Significance — RECRUITING · PHASE2
• Comparison of Etamsylate Versus Placebo to Prevent Bleeding in HSCT — RECRUITING · PHASE3
• STrategies for Anticoagulation in Patients With thRombocytopenia and Cancer-associated Thrombosis — RECRUITING · PHASE4
• Herombopag Treated T-DM1 Induced Platelet Reduction — RECRUITING · PHASE2
• Platelet-Directed Whole Blood Transfusion Strategy for Malaria — RECRUITING · NA
• Umbilical Cord Blood Megakaryocyte Injection (XJ-MK-002) for Cancer Therapy-Induced Thrombocytopenia (CTIT) — RECRUITING · PHASE1
• Anti-CD38 Antibody Treating APS With Thrombocytopenia — RECRUITING · PHASE2
• Optimizing Pulsatility During Cardiopulmonary Bypass to Reduce Acute Kidney Injury — RECRUITING · NA
• Telitacicept for the Treatment of Connective Tissue Disease-associated Thrombocytopenia — RECRUITING · PHASE2
• UCMSC-Exo for Chemotherapy-induced Myelosuppression in Acute Myeloid Leukemia — RECRUITING · PHASE1
• Evaluation of Immune Status Before and After Splenectomy in Immune Thrombocytopenia Patients — RECRUITING
• Safety and Efficacy of Zanubrutinib in the Treatment of Antiphospholipid Syndrome With Secondary Thrombocytopenia — RECRUITING · PHASE2
• Lusutrombopag Combined With Recombinant Human Thrombopoietin for the Treatment of Thrombocytopenia in Patients With Chronic Liver Disease Destined to Undergo Elective Invasive Surgery — RECRUITING · PHASE2
• Efficacy and Safety of Avatrombopag in the Treatment of Thrombocytopenia After Haplo-HSCT — RECRUITING · PHASE2
• Clinical Study on Efficacy and Safety of Hetrombopag in the Preoperative Patients of Thrombocytopenia — RECRUITING · PHASE4
• Function of Platelets Used for Transfusions — RECRUITING
• AN INTERVENTIONAL PHASE 2, OPEN-LABEL, ONE-ARM, MULTICENTER STUDY TO EVALUATE SAFETY AND EFFICACY OF PF-06835375 IN ADULT PARTICIPANTS WITH MODERATE TO SEVERE PRIMARY IMMUNE THROMOBOCYTOPENIA — RECRUITING · PHASE2
• A RANDOMIZED CONTROLLED PHASE 3 STUDY OF ORAL PACRITINIB VERSUS BEST AVAILABLE THERAPY IN PATIENTS WITH THROMBOCYTOPENIA AND PRIMARY MYELOFIBROSIS, POST-POLYCYTHEMIA VERA MYELOFIBROSIS, OR POST-ESSENTIAL THROMBOCYTHEMIA MYELOFIBROSIS. — RECRUITING · PHASE3
• Complement (C1q) Binding to HLA Antibodies in a Solid-phase Immunoassay and Clinical Effect on Platelet Transfusion — COMPLETED
• Retrospective Study of Romiplostim for Platelet Engraftment After Allo-HSCT — COMPLETED
• Efficacy and Safety of MegaLT Injection for Platelet Recovery After Umbilical Cord Blood Transplantation — NOT_YET_RECRUITING · PHASE1
• EFFECT OF PLATELET CONCENTRATE TRANSFUSION ON MICROCIRCULATORY ENDOTHELIAL FUNCTION IN INTENSIVE CARE UNIT — NOT_YET_RECRUITING
• Romiplostim in Thoracic Transplantation — COMPLETED
• Role of Viscoelastometric Testing in the Development and Validation of a Clinical-biological Score for Predicting Bleeding in Patients With Malignant Haematological Disorders and Severe Thrombocytopenia — NOT_YET_RECRUITING
• A PHASE 3, RANDOMIZED, MULTICENTER, OPEN-LABEL STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ROMIPLOSTIM PLUS PREDNISO(LO)NE VS. PREDNISO(LO)NE ALONE FOR THE TREATMENT OF ADULTS WITH PREVIOUSLY UNTREATED PRIMARY IMMUNE THROMBOCYTOPENIA (ITP) — NOT_YET_RECRUITING · PHASE3
• Collection of the Thrombo-VaxCov Cohort — WITHDRAWN
• 177Lu-PSMA-617 in Metastatic Castration Resistant Prostate Cancer (mCRPC) With Bone Marrow Involvement and Cytopenia — WITHDRAWN · PHASE2
• Bleeding Events Before vs After Lowering Departmental Platelet Transfusion Trigger — COMPLETED
• A RANDOMIZED, MULTI-CENTER, DOUBLE-BLIND, PHASE . STUDY EVALUATING THE EFFICACY AND SAFETY OF HETROMBOPAG OLAMINE TABLETS VS PLACEBO IN PATIENTS WITH CHEMOTHERAPY-INDUCED THROMBOCYTOPENIA — NOT_YET_RECRUITING
• Managed Access Programs for ETB115, Eltrombopag — OTHER
• Using Romiplostim to Treat Low Platelet Counts During Chemotherapy in People With Lymphoma — COMPLETED · PHASE2
• A Study of PN20 for the Prevention of Chemotherapy-induced Thrombocytopenia in Lymphoma or Solid Tumor Patients — COMPLETED · PHASE1
• Bioequivalence Study of Eltrombopag Olamine Tablets in Healthy Subjects in the Fed State — COMPLETED · NA
• A Multicenter, Open-label, Randomized Controlled Trial Evaluating the Efficacy and Safety of Romiplostim N01 in the Treatment of Thrombocytopenia Associated With Concurrent/Sequential Chemoradiotherapy and Chemotherapy Combined With/Without Immunotherapy in Solid Tumors — NOT_YET_RECRUITING · NA
• The Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of HMPL-523 in Adult Subjects With Immune Thrombocytopenia (ITP) — WITHDRAWN · PHASE1
• Collection of Peripheral Blood From Patients With Hematologic Malignancies With Thrombocytopenia — COMPLETED
• A Clinical Trial of Chidamide in the Management of Refractory ITP — COMPLETED · PHASE1
• Comparative Study of Thrombocytopenia in Plasmodium Vivax and Falciparum Malaria — COMPLETED
• Hematological Disorders in EHPVO Patients — NOT_YET_RECRUITING
• Clinical Performance Evaluation of T-TAS®01 HD Chip — COMPLETED
• Efficacy of Intravenous N-Acetylcysteine in Preventing Linezolid-Induced Thrombocytopenia in Critically Ill Patients — COMPLETED · PHASE4
• Efficacy and Safety of rhTPO for the Treatment of Thrombocytopenia After Chemotherapy in AML Patients — COMPLETED · PHASE4
• The SOLID Platelet Study — TERMINATED · PHASE2
• Understanding the Risk of Blood Clots and Bleeding in Patients With Hematological Malignancies, HAT Study — COMPLETED
• Donor Stem Cell Boost in Treating Patients With Low Blood Cells After Donor Stem Cell Transplant — WITHDRAWN · NA

Refine this search